Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Submission of clarification on news items appearing in Media.more...
The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Pharma stocks slump as Trump ...more...
The Exchange has sought clarification from Aurobindo Pharma Ltd on August 1 2025 with reference to news appeared in https://www.moneycontrol.com date...more...
Aurobindo Pharma Limited has informed the Exchange about Acquisitionmore...
Intimation of acquisition of Lannett Company LLC USA by Aurobindo Pharma USA Inc a wholly owned subsidiary of the Companymore...
Intimation of entering into binding agreement for transfer of shares of Curateq Biologics s.r.o. by Helix Healthcare B.V to Curateq Biologic...more...
Aurobindo Pharma Limited has informed the Exchange about Schedule of meetmore...
Intimation of Earnings Call to be held on August 5 2025 at 8:30 AM (IST) on Unaudited Financial Results of the Company for the first quarter...more...
Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and ...more...
Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...
As of June 2025 51.82% is owned by Promoters and 48.18% by Public. Among Promoters holding Indian Promoters holds 48.75% and Foreign Promoters holds ...more...
Aurobindo Pharma announced on Tuesday that it will produce and supply the long-acting injectable HIV treatment cabotegravir across 133 count...more...
Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Submission of Certificate in terms of Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2025more...
AUROBINDO PHARMA LIMITED has informed the Exchange regarding Amalgamation/ Mergermore...
Intimation of merger of a wholly owned subsidiary with another wholly owned subsidiary.more...
Aurobindo Pharma Limited has informed the Exchange about merger of a wholly owned stepdown subsidiary with another wholly owned stepdown subsidiary o...more...
Intimation of receipt of marketing approval for trastuzumab biosimilar Dazublys from European Commission by Curateq Biologics s.r.o a wholly...more...
Enter Stock
BOARD MEETINGS Company Name : Andhra Sugars Date : 09-08-2025